AAAAAA

   
Results: 1-8 |
Results: 8

Authors: HONG WW RAK IW CIURYLA VT WILSON AM KYLSTRA JW MELTZER HY CARPENTER WT LEHMAN A ARVANITIS LA
Citation: Ww. Hong et al., MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION, Schizophrenia research, 32(1), 1998, pp. 51-58

Authors: GARNETT WR HOGAN RE RAK IW THADANI VM CEREGHINO JJ BROWN LM ZHANG YX BELENDIUK GW
Citation: Wr. Garnett et al., LONG-TERM SAFETY, EFFICACY, AND QUALITY-OF-LIFE DATA FOR CARBATROL(R)(CARBAMAZEPINE EXTENDED-RELEASE CAPSULES) IN COMPLEX PARTIAL SEIZURES, Neurology, 50(4), 1998, pp. 2048-2048

Authors: HOGAN RE MIRZA WU RAK IW THADANI VM CEREGHINO JJ GARNETT WR BROWN LM ZHANG YX BELENDIUK GW
Citation: Re. Hogan et al., 6 MONTH SAFETY, EFFICACY AND QUALITY-OF-LIFE DATA FOR CARBATROL(R) (CARBAMAZEPINE EXTENDED-RELEASE CAPSULES) IN COMPLEX PARTIAL SEIZURES, Neurology, 50(4), 1998, pp. 64001-64001

Authors: ARVANITIS LA RAK IW
Citation: La. Arvanitis et Iw. Rak, THE LONG-TERM EFFICACY AND SAFETY OF SEROQUEL (QUETIAPINE), Schizophrenia research, 24(1-2), 1997, pp. 196-197

Authors: ARVANITIS LA RAK IW
Citation: La. Arvanitis et Iw. Rak, EFFICACY, SAFETY AND TOLERABILITY OF SEROQUEL (QUETIAPINE) IN ELDERLYSUBJECTS WITH PSYCHOTIC DISORDERS, Schizophrenia research, 24(1-2), 1997, pp. 196-196

Authors: RAK IW ARVANITIS LA
Citation: Iw. Rak et La. Arvanitis, OVERVIEW OF THE EFFICACY OF SEROQUEL (QUETIAPINE), Schizophrenia research, 24(1-2), 1997, pp. 199-199

Authors: MCMANUS DQ RAK IW ARVANITIS LA
Citation: Dq. Mcmanus et al., SAFETY AND TOLERABILITY OF SEROQUEL(R)(QUETIAPINE) IN ELDERLY SUBJECTS WITH PSYCHOSIS, Neurology, 48(3), 1997, pp. 2027-2027

Authors: RAK IW ZVEITEL NA
Citation: Iw. Rak et Na. Zveitel, COMPUTER-ASSISTED AMBULATORY EEG MONITORING WITH SEIZURE AND SPIKE DETECTION ALGORITHMS INCREASED YIELD COMPARED TO AMBULATORY CASSETTE EEGMONITORING, Neurology, 44(4), 1994, pp. 10000233-10000233
Risultati: 1-8 |